Format

Send to

Choose Destination
Cell. 2009 Dec 11;139(6):1029-31. doi: 10.1016/j.cell.2009.11.038.

Switching on epigenetic therapy.

Abstract

Reversible epigenetic changes that alter gene expression are a characteristic of many cancers and other diseases. Biotech companies are taking note and are starting to develop new drugs to reverse such pathogenic "epimutations."

PMID:
20005793
DOI:
10.1016/j.cell.2009.11.038
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center